Atrial Fibrillation Trial, Recruiting NCT06548269 Sponsor: Jinan Central Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06548269
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who have had an acute (sudden-onset) stroke caused by a blood clot, with the stroke occurring within the last 14 days
  • People who have been diagnosed with a type of irregular heart rhythm called atrial fibrillation (AF) that is not caused by a heart valve problem — either before this hospital stay or during it
  • People who have given written consent to participate, or whose legal representative has done so on their behalf

Who may not be able to join:

  • People who have a pacemaker, an implantable device that corrects dangerous heart rhythms (ICD), or an implantable heart monitoring device
  • People who have had their left atrial appendage (a small pouch in the heart) surgically removed or who have had a closure device placed there
  • People whose atrial fibrillation is temporary and caused by another treatable condition
  • People whose life expectancy is estimated to be less than one year
  • People who are unlikely to be able to attend follow-up appointments — for example, those without a fixed address or those living overseas
  • People who are pregnant or currently breastfeeding
  • People who are already participating in another clinical trial that could affect how the results of this study are interpreted
  • People who the trial investigator considers unsuitable for participation for other reasons, or for whom participation may carry significant risk (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13911224991

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jinan Central Hospital
Registry
ClinicalTrials.gov
Start date
15 November 2024
Est. completion
31 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Composite endpoints of ischemic stroke, systemic embolism, myocardial infarction, major bleeding (BARC type 3-5) and all-cause mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov